WK7-nicotinic receptors

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/12

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 2:35 PM on 6/2/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

13 Terms

1
New cards

What are the three main sub-types of nicotinic receptors

Muscle, ganglionic, and CNS types.

2
New cards

What type of channel are nicotinic receptors?

Ligand-gated ion channels.

3
New cards

What does nicotine mimic at nicotinic receptors?

The action of acetylcholine (ACh).

4
New cards

Are most nicotinic agonists selective or non-selective?

Non-selective (e.g., ACh, nicotine)

5
New cards

Which nicotinic agonist is selective for muscle nAChRs?

Suxamethonium (succinylcholine) (selective)

6
New cards

What are the two mechanisms for neuromuscular block?

Competitive inhibition (tubocurarine) (non-depolarising) and depolarising block (nicotine).

7
New cards

What type of block does tubocurarine produce?

non-depolarising (competitive inhibition) which overcome by increased ach

8
New cards

What is a key characteristic of a depolarising block?

Persistent stimulation leads to desensitization and Phase II block

9
New cards

Which depolarising agents act at the NMJ?

Nicotine, ACh (with cholinesterase inhibitors), suxamethonium.

10
New cards

Why is tubocurarine no longer used clinically?

Due to side effects like hypotension and histamine release.

11
New cards

Name foursynthetic non-depolarising agents used clinically

Pancuronium (LDOA), vecuronium(Intermmedite DOA), atracurium (intermmediate DOA) , mivacurium(SDOA)

12
New cards

What is the clinical use of suxamethonium?

used for brief neuromuscular block like Short-term paralysis for tracheal intubation.

13
New cards

What are the side effects of suxamethonium?

Prolonged paralysis in neonates, liver disease, or genetic variants lacking cholinesterase.